Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 29
1.
Clin Radiol ; 79(4): e554-e559, 2024 Apr.
Article En | MEDLINE | ID: mdl-38453389

AIM: To compare the radiation dose, image quality, and conspicuity of pancreatic ductal adenocarcinoma (PDAC) in pancreatic protocol dual-energy computed tomography (CT) between two X-ray tubes mounted in the same CT machine. MATERIAL AND METHODS: This retrospective study comprised 80 patients (median age, 73 years; 45 men) who underwent pancreatic protocol dual-energy CT from January 2019 to March 2022 using either old (Group A, n=41) or new (Group B, n=39) X-ray tubes mounted in the same CT machine. The imaging parameters were completely matched between the two groups, and CT data were reconstructed at 70 and 40 keV. The CT dose-index volume (CTDIvol); CT attenuation of the abdominal aorta, pancreas, and PDAC; background noise; and qualitative scores for the image noise, overall image quality, and PDAC conspicuity were compared between the two groups. RESULTS: The CTDIvol was lower in Group B than Group A (7.9 versus 9.2 mGy; p<0.001). The CT attenuation of all anatomical structures at 70 and 40 keV was comparable between the two groups (p=0.06-0.78). The background noise was lower in Group B than Group A (12 versus 14 HU at 70 keV, p=0.046; and 26 versus 30 HU at 40 keV, p<0.001). Qualitative scores for image noise and overall image quality at 70 and 40 keV and PDAC conspicuity at 40 keV were higher in Group B than Group A (p<0.001-0.045). CONCLUSION: The latest X-ray tube could reduce the radiation dose and improve image quality in pancreatic protocol dual-energy CT.


Carcinoma, Pancreatic Ductal , Pancreatic Neoplasms , Radiography, Dual-Energy Scanned Projection , Male , Humans , Aged , Radiographic Image Enhancement/methods , Retrospective Studies , X-Rays , Tomography, X-Ray Computed/methods , Pancreatic Neoplasms/diagnostic imaging , Pancreas/diagnostic imaging , Carcinoma, Pancreatic Ductal/diagnostic imaging , Radiographic Image Interpretation, Computer-Assisted/methods , Radiation Dosage , Radiography, Dual-Energy Scanned Projection/methods
2.
Clin Radiol ; 79(6): e791-e798, 2024 Jun.
Article En | MEDLINE | ID: mdl-38403540

AIM: To evaluate arterial enhancement, its depiction, and image quality in low-tube potential whole-body computed tomography (CT) angiography (CTA) with extremely low iodine dose and compare the results with those obtained by hybrid-iterative reconstruction (IR) and deep-learning image-reconstruction (DLIR) methods. MATERIALS AND METHODS: This prospective study included 34 consecutive participants (27 men; mean age, 74.2 years) who underwent whole-body CTA at 80 kVp for evaluating aortic diseases between January and July 2020. Contrast material (240 mg iodine/ml) with simultaneous administration of its quarter volume of saline, which corresponded to 192 mg iodine/ml, was administered. CT raw data were reconstructed using adaptive statistical IR-Veo of 40% (hybrid-IR), DLIR with medium- (DLIR-M), and high-strength level (DLIR-H). A radiologist measured CT attenuation of the arteries and background noise, and the signal-to-noise ratio (SNR) was then calculated. Two reviewers qualitatively evaluated the arterial depictions and diagnostic acceptability on axial, multiplanar-reformatted (MPR), and volume-rendered (VR) images. RESULTS: Mean contrast material volume and iodine weight administered were 64.1 ml and 15.4 g, respectively. The SNRs of the arteries were significantly higher in the following order of the DLIR-H, DLIR-M, and hybrid-IR (p<0.001). Depictions of six arteries on axial, three arteries on MPR, and four arteries on VR images were significantly superior in the DLIR-M or hybrid-IR than in the DLIR-H (p≤0.009 for each). Diagnostic acceptability was significantly better in the DLIR-M and DLIR-H than in the hybrid-IR (p<0.001-0.005). CONCLUSION: DLIR-M showed well-balanced arterial depictions and image quality compared with the hybrid-IR and DLIR-H.


Computed Tomography Angiography , Contrast Media , Deep Learning , Radiation Dosage , Whole Body Imaging , Humans , Male , Female , Aged , Prospective Studies , Computed Tomography Angiography/methods , Contrast Media/administration & dosage , Whole Body Imaging/methods , Radiographic Image Interpretation, Computer-Assisted/methods , Algorithms , Middle Aged , Aged, 80 and over , Aortic Diseases/diagnostic imaging
3.
Clin Radiol ; 77(2): e138-e146, 2022 02.
Article En | MEDLINE | ID: mdl-34782114

AIM: To evaluate the computed tomography (CT) attenuation values, background noise, arterial depiction, and image quality in whole-body dual-energy CT angiography (DECTA) at 40 keV with a reduced iodine dose using deep-learning image reconstruction (DLIR) and compare them with hybrid iterative reconstruction (IR). MATERIAL AND METHODS: Whole-body DECTA with a reduced iodine dose (200 mg iodine/kg) was performed in 22 patients, and DECTA data at 1.25-mm section thickness with 50% overlap were reconstructed at 40 keV using 40% adaptive statistical iterative reconstruction with Veo (hybrid-IR group), and DLIR at medium and high levels (DLIR-M and DLIR-H groups). The CT attenuation values of the thoracic and abdominal aortas and iliac artery and background noise were measured. Arterial depiction and image quality on axial, multiplanar reformatted (MPR), and volume-rendered (VR) images were assessed by two readers. Quantitative and qualitative parameters were compared between the hybrid-IR, DLIR-M, and DLIR-H groups. RESULTS: The vascular CT attenuation values were almost comparable between the three groups (p=0.013-0.97), but the background noise was significantly lower in the DLIR-H group than in the hybrid-IR and DLIR-M groups (p<0.001). The arterial depictions on axial and MPR images and in almost all arteries on VR images were comparable (p=0.14-1). The image quality of axial, MPR, and VR images was significantly better in the DLIR-H group (p<0.001-0.015). CONCLUSION: DLIR significantly reduced background noise and improved image quality in DECTA at 40 keV compared with hybrid-IR, while maintaining the arterial depiction in almost all arteries.


Aortic Diseases/diagnostic imaging , Computed Tomography Angiography/methods , Deep Learning , Iodine , Radiographic Image Enhancement/methods , Radiographic Image Interpretation, Computer-Assisted/methods , Aged , Aged, 80 and over , Contrast Media , Female , Humans , Male , Middle Aged , Radiography, Dual-Energy Scanned Projection/methods , Whole Body Imaging/methods
4.
Clin Radiol ; 76(9): 710.e15-710.e24, 2021 Sep.
Article En | MEDLINE | ID: mdl-33879322

AIM: To evaluate the use of deep-learning-based image reconstruction (DLIR) algorithms in dynamic contrast-enhanced computed tomography (CT) of the abdomen, and to compare the image quality and lesion conspicuity among the reconstruction strength levels. MATERIALS AND METHODS: This prospective study included 59 patients with 373 hepatic lesions who underwent dynamic contrast-enhanced CT of the abdomen. All images were reconstructed using four reconstruction algorithms, including 40% adaptive statistical iterative reconstruction-Veo (ASiR-V) and DLIR at low, medium, and high-strength levels (DLIR-L, DLIR-M, and DLIR-H, respectively). The signal-to-noise ratio (SNR) of the abdominal aorta, portal vein, liver, pancreas, and spleen and the lesion-to-liver contrast-to-noise ratio (CNR) were calculated and compared among the four reconstruction algorithms. The diagnostic acceptability was qualitatively assessed and compared among the four reconstruction algorithms and the conspicuity of hepatic lesions was compared between <5 and ≥5 mm lesions. RESULTS: The SNR of each anatomical structure (p<0.0001) and CNR (p<0.0001) were significantly higher in DLIR-H than the other reconstruction algorithms. Diagnostic acceptability was significantly better in DLIR-M than the other reconstruction algorithms (p<0.0001). The conspicuity of hepatic lesions was highest when using 40% ASiR-V and tended to lessen as the reconstruction strength level was getting higher in DLIR, especially in <5 mm lesions; however, all hepatic lesions could be detected. CONCLUSIONS: DLIR improved the SNR, CNR, and image quality compared with 40% ASiR-V, while making it possible to decrease lesion conspicuity using higher reconstruction strength.


Abdominal Neoplasms/diagnostic imaging , Contrast Media , Deep Learning , Radiographic Image Enhancement/methods , Radiographic Image Interpretation, Computer-Assisted/methods , Tomography, X-Ray Computed/methods , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prospective Studies , Radiography, Abdominal/methods
5.
Clin Radiol ; 75(4): 320.e17-320.e23, 2020 04.
Article En | MEDLINE | ID: mdl-31879024

AIM: To evaluate the value of virtual monochromatic images (VMIs) at lower energy levels in fast-voltage-switching dual-energy computed tomography (DECT) for assessing pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND METHODS: The institutional review board approved this prospective study. Written informed consent was obtained from all patients. Seventy-four consecutive patients with PDAC underwent dynamic contrast-enhanced DECT. Two radiologists reviewed eight energy levels (40, 45, 50, 55, 60, 65, 70, and 75 keV) of the pancreatic parenchymal phase VMIs. CT attenuation of the PDAC and pancreatic parenchyma, background noise, signal-to-noise ratio (SNR) of the pancreas, tumour-to-pancreas contrast-to-noise ratio (CNR), major and minor axes of PDAC, and qualitative tumour conspicuity were compared among the VMIs at eight energy levels. RESULTS: CT attenuation of PDAC and pancreatic parenchyma, background noise, SNR, and CNR peaked on VMIs at 40 keV with statistically significant difference (p<0.0001) and gradually decreased with increasing energy levels. The reproducibility in measuring tumour size was better on VMIs at 40 keV (28.8 and 29.2 mm of major axis in readers 1 and 2, respectively) and tended to be overestimated at higher energy levels (29.8 and 30.9 mm of major axis at 75 keV in readers 1 and 2, respectively). Qualitative tumour conspicuity was also significantly superior on VMIs at 40 keV than at all other energy levels (p<0.0001). CONCLUSION: VMIs at 40 keV demonstrated significantly increased SNR of the pancreas, CNR, and tumour conspicuity and high reproducibility in measuring tumour size for assessing PDAC.


Adenocarcinoma/diagnostic imaging , Carcinoma, Pancreatic Ductal/diagnostic imaging , Pancreatic Neoplasms/diagnostic imaging , Radiography, Dual-Energy Scanned Projection/methods , Tomography, X-Ray Computed/methods , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prospective Studies , Reproducibility of Results , Signal-To-Noise Ratio
6.
J Neurol ; 259(2): 318-26, 2012 Feb.
Article En | MEDLINE | ID: mdl-21850388

Our aim was to determine regional brain atrophy in Parkinson's disease (PD) patients with excessive daytime sleepiness (EDS) using voxel-based morphometry (VBM). From 71 consecutive probable PD patients, nine non-demented and non-hallucinating patients with an Epworth Sleepiness Scale (ESS) ≥ 10 and 13 PD patients with an ESS ≤ 3 were selected as having EDS and as not having EDS, respectively. We also enrolled 22 healthy age- and sex-matched controls. Regional brain atrophy was assessed using VBM with 3-T magnetic resonance imaging. There was no difference in the dosage of dopaminergic drugs between PD patients with EDS and PD patients without EDS. PD patients with EDS showed marked atrophy in the gray matter of the frontal lobe, temporal lobe, occipital lobe, limbic lobe including the nucleus basalis of Meynert compared to controls (false discovery rate corrected p < 0.05). In contrast, PD patients without EDS did not show any significant difference in gray matter atrophy compared to controls (false discovery rate corrected p < 0.05). PD patients with EDS showed significant atrophy of the frontal lobe, temporal lobe, occipital lobe, limbic lobe including the nucleus basalis of Meynert compared to PD patients without EDS (uncorrected p < 0.001). PD patients with EDS, even without dementia and hallucination, showed significant gray matter atrophy compared to PD patients without EDS and controls.


Brain/pathology , Disorders of Excessive Somnolence/etiology , Disorders of Excessive Somnolence/pathology , Parkinson Disease/complications , Parkinson Disease/pathology , Aged , Atrophy , Female , Humans , Image Interpretation, Computer-Assisted , Magnetic Resonance Imaging , Male
7.
Neuroscience ; 165(4): 1476-89, 2010 Feb 17.
Article En | MEDLINE | ID: mdl-19958811

The transient receptor potential vanilloid-1 (TRPV1) receptor acts as a polymodal nociceptor activated by capsaicin, heat, and acid. TRPV1, which is expressed in sensory neurons innervating the oral cavity, is associated with an oral burning sensation in response to spicy food containing capsaicin. However, little is known about the involvement of TRPV1 in responses to acid stimuli in either the gustatory system or the general somatosensory innervation of the oropharynx. To test this possibility, we recorded electrophysiological responses to several acids (acetic acid, citric acid and HCl) and other taste stimuli from the mouse chorda tympani, glossopharyngeal and superior laryngeal nerves, and compared potential effects of iodo-resiniferatoxin (I-RTX), a potent TRPV1 antagonist, on chemical responses of the three nerves. The results indicated that in the chorda tympani nerve, I-RTX (1-100 nM) did not affect responses to acids, sucrose and quinine HCl, but reduced responses to NaCl (I-RTX at concentrations of 10 and 100 nM) and KCl and NH(4)Cl (100 nM). In contrast, in the glossopharyngeal nerve, I-RTX significantly suppressed responses to all acids and salts, but not to sucrose and quinine HCl. Responses to acetic acid were suppressed by I-RTX even at 0.1 nM concentration. The superior laryngeal nerve responded in a concentration-dependent manner to acetic acid, citric acid, HCl, KCl, NH(4)Cl and monosodium l-glutamate. The responses to acetic acid, but not to the other stimuli, were significantly inhibited by I-RTX. These results suggested that TRPV1 may be involved in the mechanism for responses to acids presented to the posterior oral cavity and larynx. This high degree of responsiveness to acetic acid may account for the oral burning sensation, known as a flavor characteristic of vinegar.


Acids , Chorda Tympani Nerve/physiology , Glossopharyngeal Nerve/physiology , Laryngeal Nerves/physiology , TRPV Cation Channels/metabolism , Taste , Acetic Acid , Animals , Chorda Tympani Nerve/drug effects , Citric Acid , Diterpenes/pharmacology , Female , Food Additives , Glossopharyngeal Nerve/drug effects , Hydrochloric Acid , Laryngeal Nerves/drug effects , Male , Mice , Mice, Inbred C57BL , Quinine , Salts , Sodium Glutamate , Sucrose , Sweetening Agents , TRPV Cation Channels/antagonists & inhibitors , Taste/physiology
8.
Neurology ; 72(7): 621-6, 2009 Feb 17.
Article En | MEDLINE | ID: mdl-19221295

OBJECTIVE: To elucidate the usefulness of plasma B-type natriuretic peptide (BNP) values for evaluating adverse effects of pergolide or cabergoline on cardiovalvulopathy in patients with Parkinson disease. METHODS: Twenty-five patients treated with pergolide or cabergoline (ergot group) and 25 patients never treated with ergot derivatives (non-ergot group) were enrolled. Plasma BNP values and detailed echocardiography were evaluated. Thirty age- and gender-matched controls were similarly evaluated. RESULTS: Patients with regurgitation more than grade 3 were more frequent in the ergot group than in the non-ergot group as well as control groups (24%, 0%, 3%, p = 0.001). Both composite regurgitation scores and plasma BNP values were significantly higher in the ergot group than in controls. In the ergot group, the cumulative dose correlated to both tenting area (r = 0.57, p = 0.004) and tenting distance (r = 0.62, p = 0.001). Furthermore, plasma BNP values were higher in patients with severe or multiple regurgitation groups (p < 0.001), and were correlated with composite regurgitation score (r = 0.70, p < 0.001). Multiple regression analyses revealed that BNP values were independently correlated with both composite regurgitation and left ventricular ejection fraction. CONCLUSION: The combination of comprehensive echocardiography and plasma B-type natriuretic peptide levels elucidates the presence of cardiac damage in patients with Parkinson disease using ergot derivative dopamine agonists.


Dopamine Agonists/therapeutic use , Mitral Valve Insufficiency/blood , Natriuretic Peptide, Brain/blood , Parkinson Disease/blood , Tricuspid Valve Insufficiency/blood , Aged , Biomarkers/blood , Cohort Studies , Dopamine Agonists/adverse effects , Female , Humans , Male , Middle Aged , Mitral Valve Insufficiency/chemically induced , Mitral Valve Insufficiency/complications , Parkinson Disease/complications , Parkinson Disease/drug therapy , Tricuspid Valve Insufficiency/chemically induced , Tricuspid Valve Insufficiency/complications
9.
Gut ; 52(7): 947-52, 2003 Jul.
Article En | MEDLINE | ID: mdl-12801949

BACKGROUND AND AIMS: Ghrelin, an endogenous ligand for growth hormone secretagogue receptor (GHS-R), is an appetite stimulatory signal from the stomach with structural resemblance to motilin. We examined the effects of the gastric peptide ghrelin and GHS-R antagonists on energy balance and glycaemic control in mice. MATERIALS AND METHODS: Body weight, fat mass, glucose, insulin, and gene expression of leptin, adiponectin, and resistin in white adipose tissue (WAT) were measured after repeated administrations of ghrelin under a high fat diet. Gastric ghrelin gene expression was assessed by northern blot analysis. Energy intake and gastric emptying were measured after administration of GHS-R antagonists. Repeated administration of GHS-R antagonist was continued for six days in ob/ob obese mice. RESULTS: Ghrelin induced remarkable adiposity and worsened glycaemic control under a high fat diet. Pair feeding inhibited this effect. Ghrelin elevated leptin mRNA expression and reduced resistin mRNA expression. Gastric ghrelin mRNA expression during fasting was increased by a high fat diet. GHS-R antagonists decreased energy intake in lean mice, in mice with diet induced obesity, and in ob/ob obese mice; it also reduced the rate of gastric emptying. Repeated administration of GHS-R antagonist decreased body weight gain and improved glycaemic control in ob/ob obese mice. CONCLUSIONS: Ghrelin appears to be closely related to excess weight gain, adiposity, and insulin resistance, particularly under a high fat diet and in the dynamic stage. Gastric peptide ghrelin and GHS-R may be promising therapeutic targets not only for anorexia-cachexia but also for obesity and type 2 diabetes, which are becoming increasingly prevalent worldwide.


Eating/physiology , Intercellular Signaling Peptides and Proteins , Peptide Hormones/antagonists & inhibitors , Receptors, Cell Surface/antagonists & inhibitors , Receptors, G-Protein-Coupled , Weight Gain/physiology , Adiponectin , Adipose Tissue/metabolism , Animals , Blotting, Northern , Dietary Fats/administration & dosage , Energy Metabolism/physiology , Gastric Emptying/physiology , Gene Expression , Ghrelin , Glucose/analysis , Hormones, Ectopic/analysis , Insulin/analysis , Leptin/analysis , Male , Mice , Mice, Inbred C57BL , Mice, Obese , Nerve Growth Factor , Peptide Hormones/metabolism , Proteins/analysis , RNA, Messenger/analysis , Receptors, Ghrelin , Resistin
10.
Horm Metab Res ; 33(9): 554-8, 2001 Sep.
Article En | MEDLINE | ID: mdl-11561216

This study was designed to investigate the effects of cocaine-amphetamine-regulated transcript (CART), a recently discovered hypothalamic neuropeptide, on food intake, anxiety, oxygen consumption and gastric emptying in mice. Intracerebroventricular (i. c. v.) injection of CART (1 - 100 pmol) markedly reduced food intake in a dose-related manner. A significant decrease was observed 20 min after i. c. v. injection of CART and continued for four hours. In the elevated plus maze test, i. c. v. CART injection significantly raised the normal preference for the closed arms. Furthermore, the i. c. v. injection of CART significantly reduced oxygen consumption and gastric emptying rate. These results suggest that CART modulates feeding, emotion, and autonomic functions in mice.


Anxiety , Energy Metabolism/drug effects , Gastric Emptying/drug effects , Nerve Tissue Proteins/pharmacology , Neurotransmitter Agents/pharmacology , Animals , Eating/drug effects , Injections, Intraventricular , Male , Mice , Nerve Tissue Proteins/administration & dosage , Oxygen Consumption/drug effects
11.
Neuroendocrinology ; 74(3): 143-7, 2001 Sep.
Article En | MEDLINE | ID: mdl-11528215

Ghrelin, an endogenous ligand of the growth hormone secretagogue receptor, was recently identified in the rat stomach. Previous studies have shown that ghrelin potently increases growth hormone release and food intake. We examined the effects of the gastric peptide ghrelin on anxiety-like behavior in association with the hypothalamic-pituitary-adrenal axis in mice. Both intra-third cerebroventricular and intraperitoneal administration of ghrelin potently and significantly induced anxiogenic activities in the elevated plus maze test. Ghrelin gene expression in the stomach was increased by tail pinch stress as well as by starvation stress. Administration of a corticotropin-releasing hormone (CRH) receptor antagonist significantly inhibited ghrelin-induced anxiogenic effects. Peripherally administered ghrelin significantly increased CRH mRNA, but not urocortin mRNA expression in the hypothalamus. Furthermore, intraperitoneal injection of ghrelin produced a significant dose- dependent increase in serum corticosterone levels. These findings suggest that ghrelin may have a role in mediating neuroendocrine and behavioral responses to stressors and that the stomach could play an important role, not only in the regulation of appetite, but also in the regulation of anxiety.


Behavior, Animal/physiology , Neurosecretory Systems/physiopathology , Peptide Hormones , Peptides/physiology , Stress, Physiological/physiopathology , Stress, Physiological/psychology , Animals , Anxiety/chemically induced , Anxiety/prevention & control , Corticotropin-Releasing Hormone/genetics , Corticotropin-Releasing Hormone/pharmacology , Gene Expression , Ghrelin , Hypothalamo-Hypophyseal System/physiopathology , Male , Mice , Pain/complications , Pain/genetics , Peptide Fragments/pharmacology , Peptides/genetics , Pituitary-Adrenal System/physiopathology , RNA, Messenger/metabolism , Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors , Stomach/physiopathology , Stress, Physiological/etiology , Stress, Physiological/genetics
12.
Am J Ophthalmol ; 132(1): 131-2, 2001 Jul.
Article En | MEDLINE | ID: mdl-11438076

PURPOSE: To report a patient who had concomitant combined hamartoma of the retinal pigment epithelium and retina and juvenile nasopharyngeal angiofibroma. METHOD: Case report. RESULTS: An 18-year-old man presented with a juvenile nasopharyngeal angiofibroma and a combined hamartoma of the retina and retinal pigment epithelium in the ipsilateral eye. The diagnosis of juvenile nasopharyngeal angiofibroma was confirmed by histopathology, and the diagnosis of combined hamartoma was established by typical ophthalmoscopic and fluorescein angiographic findings. CONCLUSION: Juvenile nasopharyngeal angiofibroma may be associated with combined hamartoma of the retina and retinal pigment epithelium.


Angiofibroma/complications , Hamartoma/complications , Nasopharyngeal Neoplasms/complications , Pigment Epithelium of Eye/pathology , Retinal Diseases/complications , Adolescent , Angiofibroma/diagnostic imaging , Angiofibroma/pathology , Fluorescein Angiography , Fundus Oculi , Hamartoma/diagnostic imaging , Hamartoma/pathology , Humans , Male , Nasopharyngeal Neoplasms/diagnostic imaging , Nasopharyngeal Neoplasms/pathology , Ophthalmoscopy , Retinal Diseases/diagnostic imaging , Retinal Diseases/pathology , Tomography, X-Ray Computed
13.
Am J Ophthalmol ; 132(1): 120-1, 2001 Jul.
Article En | MEDLINE | ID: mdl-11438071

PURPOSE: To report the optical coherence tomographic characteristics of persistent bleb-like subretinal lesions after retinal reattachment surgery, including scleral buckling and cryopexy. METHODS: Case reports. RESULTS: In two eyes of two patients yellow to yellowish-orange bleb-like lesions were found in the posterior pole after retinal reattachment surgery. The common aspects of the surgery were scleral buckling procedures and cryopexy. There were subretinal precipitates in some of the lesions. The lesions showed no associated leakage during fluorescein or indocyanine green angiography. Optical coherence tomography demonstrated that the bleb-like lesions were tiny retinal detachments. CONCLUSION: Optical coherence tomography examination of bleb-like subretinal lesions showed that they were actually retinal detachments. Our patients and previously reported patients developed these lesions after scleral buckling and cryopexy. These lesions may represent persistent retinal detachment because of the presence of protein in the subretinal fluid.


Cryosurgery , Diagnostic Techniques, Ophthalmological , Retina/pathology , Retinal Detachment/diagnosis , Retinal Detachment/surgery , Scleral Buckling , Adult , Female , Humans , Interferometry , Light , Middle Aged , Tomography , Visual Acuity
14.
Diabetes ; 50(5): 1206-10, 2001 May.
Article En | MEDLINE | ID: mdl-11334428

Neuropeptide Y (NPY), one of the most abundant peptide transmitters in the mammalian brain, is assumed to play an important role in feeding and body weight regulation. However, there is little genetic evidence that overexpression or knockout of the NPY gene leads to altered body weight regulation. Previously, we developed NPY-overexpressing mice by using the Thy-1 promoter, which restricts NPY expression strictly within neurons in the central nervous system, but we failed to observe the obese phenotype in the heterozygote. Here we report that in the homozygous mice, overexpression of NPY leads to an obese phenotype, but only after appropriate dietary exposure. NPY-overexpressing mice exhibited significantly increased body weight gain with transiently increased food intake after 50% sucrose--loaded diet, and later they developed hyperglycemia and hyperinsulinemia without altered glucose excursion during 1 year of our observation period.


Arginine/analogs & derivatives , Brain/physiology , Dietary Sucrose/pharmacology , Neuropeptide Y/physiology , Obesity/physiopathology , Aging , Animals , Arginine/pharmacology , Cyclohexanes/pharmacology , Energy Intake/drug effects , Homozygote , Humans , Mice , Mice, Knockout , Mice, Transgenic , Neuropeptide Y/genetics , Obesity/chemically induced , Obesity/genetics , Phenotype , Promoter Regions, Genetic , Receptors, Neuropeptide Y/antagonists & inhibitors , Reference Values , Thy-1 Antigens/genetics , Xanthenes/pharmacology
16.
Peptides ; 22(3): 501-6, 2001 Mar.
Article En | MEDLINE | ID: mdl-11287107

The Y(2) receptor is the predominant neuropeptide Y (NPY) receptor subtype in the brain. Y(2) receptor mRNA is discretely distributed in the brain, including specific subregions of the hippocampus and the hypothalamus, and is largely consistent with the distribution of Y(2) receptor protein demonstrated by radioligand-binding methods. Y(2) receptor-mediated effects have been reported principally based on the observations using the C-terminal fragments of NPY. Recent studies indicate an involvement of the receptor in food intake, gastrointestinal motility, cardiovascular regulation, and neuronal excitability. Very recently, Y(2) receptor selective antagonist has been developed and Y(2) receptor-deficient animals have been created. These new pharmacological tools will help to clarify the roles of this receptor in brain functions.


Brain/metabolism , Receptors, Neuropeptide Y/physiology , Animals , Circadian Rhythm , Digestive System/embryology , Epilepsy/metabolism , Hippocampus/metabolism , Humans , Hypothalamus/metabolism , Memory , Neurons/metabolism , Pancreatic Polypeptide/metabolism , RNA, Messenger/metabolism , Radioligand Assay , Rats , Structure-Activity Relationship
17.
Nihon Rinsho ; 59(3): 487-96, 2001 Mar.
Article Ja | MEDLINE | ID: mdl-11268597

Obesity is, with rare exceptions, a complex phenotype resulting from interactions between environmental and genetic risk factor. Obesity is associated with diabetes, hypertension, and hyperlipidemia, leading to arteriosclerosis. Dysregulation of food intake and energy expenditure, and thus energy homeostasis, is now recognized as playing a major role in development of obesity. A detailed understanding of the physiology and genetics of the regulatory systems is critical for the development of new approaches for treating obesity and its sequelae.


Body Weight/physiology , Eating/physiology , Obesity/physiopathology , Adult , Humans , Obesity/genetics , Satiation/physiology
19.
Gastroenterology ; 120(2): 337-45, 2001 Feb.
Article En | MEDLINE | ID: mdl-11159873

BACKGROUND & AIMS: : Ghrelin, an endogenous ligand for growth hormone secretagogue receptor, was recently identified in the rat stomach. We examined the effects of the gastric peptide ghrelin on energy balance in association with leptin and vagal nerve activity. METHODS: : Food intake, oxygen consumption, gastric emptying, and hypothalamic neuropeptide Y (NPY) messenger RNA expression were measured after intra-third cerebroventricular or intraperitoneal injections of ghrelin in mice. The gastric vagal nerve activity was recorded after intravenous administration in rats. Gastric ghrelin gene expression was assessed by Northern blot analysis. Repeated coadministration of ghrelin and interleukin (IL)-1 beta was continued for 5 days. RESULTS: : Ghrelin exhibited gastroprokinetic activity with structural resemblance to motilin and potent orexigenic activity through action on the hypothalamic neuropeptide Y (NPY) and Y(1) receptor, which was lost after vagotomy. Ghrelin decreased gastric vagal afferent discharge in contrast to other anorexigenic peptides that increased the activity. Ghrelin gene expression in the stomach was increased by fasting and in ob/ob mice, and was decreased by administration of leptin and IL-1 beta. Peripherally administered ghrelin blocked IL-1 beta-induced anorexia and produced positive energy balance by promoting food intake and decreasing energy expenditure. CONCLUSIONS: : Ghrelin, which is negatively regulated by leptin and IL-1 beta, is secreted by the stomach and increases arcuate NPY expression, which in turn acts through Y(1) receptors to increase food intake and decrease energy expenditure. Gastric peptide ghrelin may thus function as part of the orexigenic pathway downstream from leptin and is a potential therapeutic target not only for obesity but also for anorexia and cachexia.


Appetite/physiology , Motilin/genetics , Peptide Hormones , Peptides/genetics , Peptides/pharmacology , Stomach/physiology , Amino Acid Sequence , Animals , Blotting, Northern , Electrophysiology , Energy Metabolism/drug effects , Energy Metabolism/physiology , Feeding Behavior/drug effects , Feeding Behavior/physiology , Gastric Emptying/drug effects , Gastric Emptying/physiology , Gene Expression/physiology , Ghrelin , Hypothalamus/physiology , Injections, Intraventricular , Interleukin-1/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Obese , Molecular Sequence Data , Motilin/chemistry , Neuropeptide Y/genetics , Oxygen Consumption/drug effects , Oxygen Consumption/physiology , Peptides/chemistry , RNA, Messenger/analysis , Rats , Rats, Wistar , Receptors, Gastrointestinal Hormone/genetics , Receptors, Neuropeptide/genetics , Stomach/innervation , Vagus Nerve/drug effects , Vagus Nerve/physiology
...